83537-034Level 3
KRESLADI (MARNETEGRAGENE AUTOTEMCEL)
**Product type:** Cellular Therapy
**Active ingredient:** MARNETEGRAGENE AUTOTEMCEL
**Strength:** 6100000 1/mL
**Dosage form:** Injection, Suspension
**Route:** Intravenous
**Labeler:** Rocket Pharmaceuticals, Inc.
**Marketing category:** BLA (BLA125806)
GET
/api/v1/systems/ndc_fda/nodes/83537-034Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.